- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 86.05M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $343.79M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $343.68M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $358.2M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $418.8M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $153.99M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $154.08M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $94.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $103.55M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $425.65M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $436.69M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $548.75M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $603.06M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $640.71M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $724.82M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 85.21M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$83.55M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $491.89M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $554.2M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.85 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $56.49M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$72.4M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$79.51M |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |